人工智能模型可提高粪便免疫化学试验(FIT)在筛查结肠腺瘤中的诊断准确性。

IF 1.6 4区 医学 Q4 ONCOLOGY
Maaret Eskelinen, Tuomas Selander, Denise Peixoto Guimarães, Kai Kaarniranta, Kari Syrjänen, Matti Eskelinen
{"title":"人工智能模型可提高粪便免疫化学试验(FIT)在筛查结肠腺瘤中的诊断准确性。","authors":"Maaret Eskelinen, Tuomas Selander, Denise Peixoto Guimarães, Kai Kaarniranta, Kari Syrjänen, Matti Eskelinen","doi":"10.21873/anticanres.17414","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using five artificial intelligence (AI) models: logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). These models were tested together with clinical features categorized as low-risk (lowR) and high-risk (highR).</p><p><strong>Patients and methods: </strong>The colorectal neoplasia (CRN) screening cohort of 5,090 patients included 222 CRA patients and 264 non-CRA patients. Three consecutive fecal samples from each individual were analyzed by two fecal occult blood (FOB) assays. Five AI models including clinical features of CRN patients and CV test results were used to test the DA for CRA measured by receiving operating characteristic (ROC) curves.</p><p><strong>Results: </strong>In conventional ROC analysis, the area under the curve (AUC) values for different AI models ranged from 0.659 and 0.691 (for AIs with LR and SVM), while the highest AUC values were reached by NN, RF, and GBM models (0.809, 0.840, and 0.858, respectively). In the hierarchical summary ROC (HSROC) analysis, the AUC values were as follows: i) with lowR variables, AUC=0.508; ii) with highR variables, AUC=0.566 and iii) with all AI models, AUC= 0.789. The differences in AUC values were: between i) and ii) p=0.008; between i) and iii) p<0.0001 and between ii) and iii) p<0.0001.</p><p><strong>Conclusion: </strong>In detection of CRA, the AI models proved to be superior to the diagnostic features without AI. This is the first study to report that DA in the diagnosis of CRA can be enhanced by AI models that include clinical data of the patients and results of FIT test.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"45 1","pages":"267-275"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.\",\"authors\":\"Maaret Eskelinen, Tuomas Selander, Denise Peixoto Guimarães, Kai Kaarniranta, Kari Syrjänen, Matti Eskelinen\",\"doi\":\"10.21873/anticanres.17414\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using five artificial intelligence (AI) models: logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). These models were tested together with clinical features categorized as low-risk (lowR) and high-risk (highR).</p><p><strong>Patients and methods: </strong>The colorectal neoplasia (CRN) screening cohort of 5,090 patients included 222 CRA patients and 264 non-CRA patients. Three consecutive fecal samples from each individual were analyzed by two fecal occult blood (FOB) assays. Five AI models including clinical features of CRN patients and CV test results were used to test the DA for CRA measured by receiving operating characteristic (ROC) curves.</p><p><strong>Results: </strong>In conventional ROC analysis, the area under the curve (AUC) values for different AI models ranged from 0.659 and 0.691 (for AIs with LR and SVM), while the highest AUC values were reached by NN, RF, and GBM models (0.809, 0.840, and 0.858, respectively). In the hierarchical summary ROC (HSROC) analysis, the AUC values were as follows: i) with lowR variables, AUC=0.508; ii) with highR variables, AUC=0.566 and iii) with all AI models, AUC= 0.789. The differences in AUC values were: between i) and ii) p=0.008; between i) and iii) p<0.0001 and between ii) and iii) p<0.0001.</p><p><strong>Conclusion: </strong>In detection of CRA, the AI models proved to be superior to the diagnostic features without AI. This is the first study to report that DA in the diagnosis of CRA can be enhanced by AI models that include clinical data of the patients and results of FIT test.</p>\",\"PeriodicalId\":8072,\"journal\":{\"name\":\"Anticancer research\",\"volume\":\"45 1\",\"pages\":\"267-275\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anticancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/anticanres.17414\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17414","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:本研究利用logistic回归(LR)、支持向量机(SVM)、神经网络(NN)、随机森林(RF)和梯度增强机(GBM) 5种人工智能(AI)模型,对粪便免疫化学试验(FIT)筛选的结直肠腺瘤(CRA)的诊断准确性(DA)进行评估。这些模型与低风险(lowR)和高风险(highR)的临床特征一起进行测试。患者与方法:结直肠肿瘤(CRN)筛查队列共5090例,其中CRA患者222例,非CRA患者264例。通过两次粪便潜血(FOB)分析每个个体连续三次的粪便样本。采用包括CRN患者临床特征和CV检验结果在内的5个AI模型,检验接受工作特征(ROC)曲线测量的CRA DA。结果:在常规的ROC分析中,不同人工智能模型的曲线下面积(AUC)值在0.659和0.691之间(LR和SVM的人工智能),而NN、RF和GBM模型的AUC值最高,分别为0.809、0.840和0.858。在分层汇总ROC (HSROC)分析中,AUC值如下:i)低r变量下,AUC=0.508;ii)对于高r变量,AUC=0.566; iii)对于所有AI模型,AUC= 0.789。AUC值的差异为:i)和ii) p=0.008;结论:在CRA的检测中,人工智能模型优于无人工智能的诊断特征。该研究首次报道了人工智能模型可以增强DA在CRA诊断中的作用,该模型包括患者的临床数据和FIT测试结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.

Background/aim: This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using five artificial intelligence (AI) models: logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). These models were tested together with clinical features categorized as low-risk (lowR) and high-risk (highR).

Patients and methods: The colorectal neoplasia (CRN) screening cohort of 5,090 patients included 222 CRA patients and 264 non-CRA patients. Three consecutive fecal samples from each individual were analyzed by two fecal occult blood (FOB) assays. Five AI models including clinical features of CRN patients and CV test results were used to test the DA for CRA measured by receiving operating characteristic (ROC) curves.

Results: In conventional ROC analysis, the area under the curve (AUC) values for different AI models ranged from 0.659 and 0.691 (for AIs with LR and SVM), while the highest AUC values were reached by NN, RF, and GBM models (0.809, 0.840, and 0.858, respectively). In the hierarchical summary ROC (HSROC) analysis, the AUC values were as follows: i) with lowR variables, AUC=0.508; ii) with highR variables, AUC=0.566 and iii) with all AI models, AUC= 0.789. The differences in AUC values were: between i) and ii) p=0.008; between i) and iii) p<0.0001 and between ii) and iii) p<0.0001.

Conclusion: In detection of CRA, the AI models proved to be superior to the diagnostic features without AI. This is the first study to report that DA in the diagnosis of CRA can be enhanced by AI models that include clinical data of the patients and results of FIT test.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Anticancer research
Anticancer research 医学-肿瘤学
CiteScore
3.70
自引率
10.00%
发文量
566
审稿时长
2 months
期刊介绍: ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信